AUTL

Autolus Therapeutics PLC

Price

$1.93

return (12m)

43.66%

p/e

-1.83

p/bv

6.85

DIVIDEND YIELD

0.00%

AUTL price

Autolus Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AUTL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-20.29%

3 months

27.48%

1 year

43.66%

2 years

-50.00%

5 years

-69.87%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AUTL

Valuation

P/E

-1.83

Sector -3.50

Industry -3.50

P/BV

6.85

Sector 2.02

Industry 2.02

P/Revenue (PSR)

4.36

Sector 2.01

Industry 2.01

EV/EBITDA

-8.04

Sector -214.99

Industry -214.99

EV/EBIT

-7.52

Sector -47.59

Industry -47.59

P/EBITDA

-2.26

Sector -21.41

Industry -21.41

P/EBIT

-2.16

Sector -28.65

Industry -28.65

P/Total Assets

1.04

Sector 1.19

Industry 1.19

P/Net Current Assets

-6.23

Sector -11.97

Industry -11.97

P/Working Capital

1.92

Sector -167.95

Industry -167.95

EPS

-1.05

Sector -1.81

Industry -1.81

BVPS

0.28

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

15.66%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-84.64%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-90.44%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.09

Sector 0.02

Industry 0.02

Profitability

ROE

-374.35%

Sector -56.04%

Industry -56.04%

ROA

-56.80%

Sector -60.31%

Industry -60.31%

ROIC

-63.78%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.89

Sector 2.89

Industry 2.89

Net Debt / EBITDA

5.21

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

4.88

Sector -8.06

Industry -8.06

Net Debt / Equity

-2.69

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.15

Sector 0.46

Industry 0.46

Liabilities/Assets

0.85

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

119.01%

Sector -

Industry -

5Y Earnings CAGR

14.54%

Sector -

Industry -

Fundamentals AUTL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AUTL Autolus Therapeutics PLC	$1.93	51.57%	0.00%	-1.83	6.85	-374.35%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.09%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	42.33%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.88%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AUTL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Autolus Therapeutics

Autolus Therapeutics PLC

Average Investor10 user rating

4.0 (2 people)

United States

8 years

Founded: 2018

2018

Time since IPO - 8 years

384

Employees

Autolus Therapeutics PLC (United States) is listed on the Nasdaq and has a market capitalization of $512.36 million, with shareholders equity totaling $74.84 million.

The company employs approximately 384 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Autolus Therapeutics PLC reported $117.39 million in revenue, generating net income of $-280.16 million.

Key financial metrics include a P/E ratio of -1.83, a price-to-book (P/B) ratio of 6.85, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AUTL.

Market cap

$512.36 million

Net worth

$74.84 million

$74,839,000.00

Assets

$493.23 million

$493,226,000.00

Total Shares Outstanding

266.16 million

266,158,000

Average Daily Trading Volume

$2.25 million

$2,246,809.18

Sector

Health Care

Industry

Biotechnology

AUTL

AUTL revenue and profits

Financial Results AUTL

DRAG THE FRAME TO SEE MORE DATA

AUTL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,90% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$224.45 51,94% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 86,25% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,90% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$224.45 51,94% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 86,25% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Autolus Therapeutics (AUTL) today?

A cotação de Autolus Therapeutics (AUTL) hoje está em US$ 1.93, com uma variação de 43.66% em relação ao último ano. A cotação de Autolus Therapeutics (AUTL) iniciou o ano negociando na casa dos US$ 1.99 e hoje está em US$ 1.93. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Autolus Therapeutics (AUTL) e dados de ações do Ibovespa e mercados internacionais.

Quando Autolus Therapeutics (AUTL) paga dividendos?

Autolus Therapeutics (AUTL) não distribuiu dividendos no último ano.

Is Autolus Therapeutics (AUTL) a good investment?

Atualmente, Autolus Therapeutics (AUTL) está cotada a US$ 1.93, com um P/L de -1.83, representando um desvio de -345% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 43.66 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 43.66%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Autolus Therapeutics (AUTL) stock?

Investir em ações de Autolus Therapeutics (AUTL) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Autolus Therapeutics (AUTL) yield today?

A rentabilidade de Autolus Therapeutics (AUTL) foi de -20.29% no último mês, 43.66% no último ano e -69.87% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Autolus Therapeutics (AUTL) hoje, o investimento total seria de US$ 192.50, com base na cotação atual de US$ 1.93.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 276.55
Em 5 anos: US$ 58.00
Em 10 anos: US$ 192.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AUTL

Autolus Therapeutics PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AUTL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING AUTL WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Autolus Therapeutics

Autolus Therapeutics PLC

United States

8 years

2018

384

PROFIT X PRICE AUTL

Financial Results AUTL

AUTL cash flow

Asset, Revenue and Profit Growth - AUTL

AUTL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions